These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2857256)

  • 41. [Virulence of BCG and induction of cellular immunity (2)].
    Miura K; Takahashi H; Murohashi T; Hashimoto T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):255. PubMed ID: 765561
    [No Abstract]   [Full Text] [Related]  

  • 42. Mycobacterium xenopi and pulmonary disease.
    Koizumi JH; Sommers HM
    Am J Clin Pathol; 1980 Jun; 73(6):826-30. PubMed ID: 6994481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nontuberculous mycobacteria pathogenesis and biofilm assembly.
    Sousa S; Bandeira M; Carvalho PA; Duarte A; Jordao L
    Int J Mycobacteriol; 2015 Mar; 4(1):36-43. PubMed ID: 26655196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare.
    Gangadharam PR; Edwards CK
    Am Rev Respir Dis; 1984 Nov; 130(5):834-8. PubMed ID: 6093657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of surface-active agents on Mycobacterium tuberculosis and Mycobacterium bovis. Obtaining chromogenic mycobacteria].
    Lafont J; Lafont P
    Can J Microbiol; 1978 Mar; 24(3):261-7. PubMed ID: 417788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The virulence of some strains of BCG for golden hamsters.
    Bunch-Christensen K; Ladefoged A; Guld J
    Bull World Health Organ; 1968; 39(5):821-8. PubMed ID: 4893582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LYMPH GLAND PROCESSES CAUSED BY ATYPICAL MYCOBACTERIA AND MYCOBACTERIUM AVIUM. BACTERIOLOGICALLY VERIFIED CASES IN DENMARK FROM 1935 TO 1961.
    ENGBAEK HC
    Acta Tuberc Pneumol Scand; 1964; 44():108-37. PubMed ID: 14165365
    [No Abstract]   [Full Text] [Related]  

  • 49. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of mycobacterial virulence and culture condition on gamma delta T cell activation.
    Schoel B; Kaufmann SH
    Microb Pathog; 1998 Mar; 24(3):197-201. PubMed ID: 9514640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid differentiation of Mycobacterium xenopi from mycobacteria of the Mycobacterium avium-intracellulare complex by pyrolysis mass spectrometry.
    Sisson PR; Freeman R; Magee JG; Lightfoot NF
    J Clin Pathol; 1992 Apr; 45(4):355-7. PubMed ID: 1577977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sensitivity of the protection test in guinea pigs vaccinated by BCG. I. Influence of age or slight viability margins of BCG cultures].
    Frappier A; Portelance V; Marois P; St-Pierre J
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):425-47. PubMed ID: 4860409
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunoassays of field isolates of Mycobacterium bovis and other mycobacteria by use of monoclonal antibodies.
    Morris JA; Ivanyi J
    J Med Microbiol; 1985 Jun; 19(3):367-73. PubMed ID: 2409287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyclonal antibodies raised against Bacillus Calmette-Guerin, Mycobacterium duvalii, and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques.
    Wiley EL; Mulhollan TJ; Beck B; Tyndall JA; Freeman RG
    Am J Clin Pathol; 1990 Sep; 94(3):307-12. PubMed ID: 1697733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin sensitivity of adults on the Isthmus of Panama to Mycobacterium xenopi sensitin.
    Larrabee WF; Talavera R
    Am J Trop Med Hyg; 1979 Jan; 28(1):106-9. PubMed ID: 434302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The mycobactericidal efficacy of ortho-phthalaldehyde and the comparative resistances of Mycobacterium bovis, Mycobacterium terrae, and Mycobacterium chelonae.
    Gregory AW; Schaalje GB; Smart JD; Robison RA
    Infect Control Hosp Epidemiol; 1999 May; 20(5):324-30. PubMed ID: 10349948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of cell accumulation induced by Mycobacterium bovis BCG.
    Menezes-de-Lima-Júnior O; Henriques M das G
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():227-32. PubMed ID: 9698940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycobacterium xenopi and Mycobacterium kansasii in a hospital water supply.
    Wright EP; Collins CH; Yates MD
    J Hosp Infect; 1985 Jun; 6(2):175-8. PubMed ID: 2862192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG.
    Hotter GS; Wards BJ; Mouat P; Besra GS; Gomes J; Singh M; Bassett S; Kawakami P; Wheeler PR; de Lisle GW; Collins DM
    J Bacteriol; 2005 Apr; 187(7):2267-77. PubMed ID: 15774869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.